Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Are the first-line recommendations for antiepileptic drug therapy still valid?

Nature Clinical Practice Neurology volume 3, pages 484–485 (2007)Cite this article

boxed-textMarson AG et al. (2007) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369: 1000–1015

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Marson AG et al. (2007) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369: 1016–1026

    Article  CAS  Google Scholar 

  2. Mattson RH et al. (1985) A comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic–clonic seizures. N Engl J Med 313: 145–151

    Article  CAS  Google Scholar 

  3. Mattson RH et al. (1992) Comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic–clonic seizures in adults. N Engl J Med 327: 765–771

    Article  CAS  Google Scholar 

  4. Rowan AJ et al. (2005) New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64: 1868–1873

    Article  CAS  Google Scholar 

  5. Brodie MJ et al. (1995) Double blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 345: 476–479

    Article  CAS  Google Scholar 

  6. Gilliam FG et al. (2005) Epilepsy and common comorbidities: improving the outpatient epilepsy encounter. Epileptic Disord 7 (Suppl 1): S27–S33

    PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Columbia University College of Physicians and Surgeons, 710 West 168th Street, New York, NY 10032, USA cwb11@columbia.edu

Authors and Affiliations

  1. C Bazil is Director of Anticonvulsant Drug Trials at the Columbia University Comprehensive Epilepsy Center, New York, NY, USA.,

    Carl Bazil

Authors
  1. Carl Bazil
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has declared associations with Eisai (consultant, grant/research support), GlaxoSmithKline (speaker honoraria), Pfizer (consultant, speaker honoraria, grant/research support), and UCB Pharma (consultant, speaker honoraria, grant/research support).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bazil, C. Are the first-line recommendations for antiepileptic drug therapy still valid?. Nat Rev Neurol 3, 484–485 (2007). https://doi.org/10.1038/ncpneuro0557

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0557

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing